Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.

This legislation aims to make life-saving diabetes management more affordable for Virginians by capping out-of-pocket costs for insulin and necessary medical supplies. Under this bill, health insurance plans regulated by the state must limit the amount a patient pays for a 30-day supply of insulin to no more than $50. Additionally, the measure prohibits insurance providers from applying deductibles to these essential medications and testing equipment. For Arlington residents living with diabetes, this change will provide predictable monthly costs and reduce the financial burden of chronic disease management. By removing the high cost-sharing barriers that often force patients to ration their medication, the law is expected to improve long-term health outcomes and prevent costly emergency medical complications for thousands of community members across the Commonwealth.